Daniel Winter Goodman
Fondateur chez Psychogenics, Inc.
Profil
Daniel Winter Goodman is the founder of Resolvyx Pharmaceuticals, Inc. (founded in 2001), Psychogenics, Inc. (founded in 1998), Riverside Pharmaceuticals Corp.
(founded in 2012), The Midtown Practice For Psychotherapy & Psychiatry (founded in 2017), and Daniel Goodman MD PC (founded in 2003).
He holds the title of President at Resolvyx Pharmaceuticals, Inc., Director at Psychogenics, Inc., Chief Executive Officer at Riverside Pharmaceuticals Corp., President at The Midtown Practice For Psychotherapy & Psychiatry, and President at Daniel Goodman MD PC.
Currently, Dr. Goodman is an Assistant Professor at Weill Cornell Medical College.
He previously worked as an Independent Director at Tonix Pharmaceuticals Holding Corp.
from 2019 to 2022.
Dr. Goodman obtained a doctorate degree from Harvard Medical School, an MBA degree from Columbia Business School, and an undergraduate degree from Yale College.
Postes actifs de Daniel Winter Goodman
| Sociétés | Poste | Début |
|---|---|---|
Psychogenics, Inc.
 Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Fondateur | 01/01/1998 |
| Riverside Pharmaceuticals Corp. | Directeur Général | 01/01/2012 |
| Weill Cornell Medical College | Corporate Officer/Principal | - |
| The Midtown Practice For Psychotherapy & Psychiatry | Fondateur | 01/01/2017 |
| Daniel Goodman MD PC | Fondateur | 01/01/2003 |
Anciens postes connus de Daniel Winter Goodman
| Sociétés | Poste | Fin |
|---|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Directeur/Membre du Conseil | 06/05/2022 |
Resolvyx Pharmaceuticals, Inc.
 Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA. | Fondateur | - |
Formation de Daniel Winter Goodman
| Harvard Medical School | Doctorate Degree |
| Columbia Business School | Masters Business Admin |
| Yale College | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Resolvyx Pharmaceuticals, Inc.
Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Psychogenics, Inc.
Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Health Technology |
| Riverside Pharmaceuticals Corp. | Miscellaneous |
| The Midtown Practice For Psychotherapy & Psychiatry | |
| Daniel Goodman MD PC |
